Cansino Net Interest Income vs Operating Income Analysis

688185 Stock   61.23  0.13  0.21%   
Cansino Biologics financial indicator trend analysis is way more than just evaluating Cansino Biologics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cansino Biologics is a good investment. Please check the relationship between Cansino Biologics Net Interest Income and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Interest Income vs Operating Income

Net Interest Income vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cansino Biologics Net Interest Income account and Operating Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cansino Biologics' Net Interest Income and Operating Income is -0.03. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Operating Income in the same time period over historical financial statements of Cansino Biologics, assuming nothing else is changed. The correlation between historical values of Cansino Biologics' Net Interest Income and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Cansino Biologics are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Net Interest Income i.e., Cansino Biologics' Net Interest Income and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.03
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Operating Income

Operating Income is the amount of profit realized from Cansino Biologics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cansino Biologics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Cansino Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cansino Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 680.2 M, whereas Tax Provision is forecasted to decline to (12 M).
 2021 2022 2023 2024 (projected)
Interest Income79.7M65.9M100.1M105.1M
Net Interest Income59.0M24.1M35.7M27.1M

Cansino Biologics fundamental ratios Correlations

0.860.950.980.970.980.84-0.070.770.920.920.840.790.60.760.840.960.750.950.91-0.670.940.641.00.880.99
0.860.90.790.850.820.79-0.370.590.660.910.780.940.880.920.890.90.950.80.8-0.590.920.620.850.990.8
0.950.90.880.910.90.74-0.030.760.770.950.740.790.660.820.810.990.790.950.91-0.580.990.580.940.930.91
0.980.790.880.940.980.85-0.070.770.970.850.860.730.50.670.820.890.660.920.88-0.690.850.610.990.80.99
0.970.850.910.940.990.86-0.260.620.860.950.860.830.660.770.930.910.780.840.85-0.680.930.750.980.850.93
0.980.820.90.980.990.86-0.170.710.920.910.870.770.570.690.890.90.710.880.89-0.690.890.680.990.820.96
0.840.790.740.850.860.86-0.410.530.780.821.00.840.660.710.860.770.760.710.72-0.780.750.850.860.780.81
-0.07-0.37-0.03-0.07-0.26-0.17-0.410.420.04-0.3-0.4-0.6-0.68-0.44-0.55-0.03-0.580.190.050.22-0.14-0.58-0.12-0.290.02
0.770.590.760.770.620.710.530.420.80.560.540.350.140.340.460.750.340.910.87-0.430.660.140.740.610.83
0.920.660.770.970.860.920.780.040.80.70.780.580.330.50.710.780.510.870.84-0.630.720.470.920.660.96
0.920.910.950.850.950.910.82-0.30.560.70.820.90.790.890.910.950.880.820.82-0.620.980.780.920.930.85
0.840.780.740.860.860.871.0-0.40.540.780.820.830.650.70.850.760.750.710.73-0.770.750.860.860.770.81
0.790.940.790.730.830.770.84-0.60.350.580.90.830.960.950.910.790.990.650.65-0.590.840.790.80.930.71
0.60.880.660.50.660.570.66-0.680.140.330.790.650.960.950.80.660.980.460.47-0.440.740.70.610.860.49
0.760.920.820.670.770.690.71-0.440.340.50.890.70.950.950.790.830.970.670.61-0.510.870.70.760.950.68
0.840.890.810.820.930.890.86-0.550.460.710.910.850.910.80.790.80.870.680.76-0.640.850.760.860.850.78
0.960.90.990.890.910.90.77-0.030.750.780.950.760.790.660.830.80.790.950.87-0.650.980.60.940.930.92
0.750.950.790.660.780.710.76-0.580.340.510.880.750.990.980.970.870.790.630.63-0.540.840.720.750.940.66
0.950.80.950.920.840.880.710.190.910.870.820.710.650.460.670.680.950.630.93-0.570.890.440.930.840.96
0.910.80.910.880.850.890.720.050.870.840.820.730.650.470.610.760.870.630.93-0.40.870.50.890.80.91
-0.67-0.59-0.58-0.69-0.68-0.69-0.780.22-0.43-0.63-0.62-0.77-0.59-0.44-0.51-0.64-0.65-0.54-0.57-0.4-0.58-0.55-0.69-0.58-0.66
0.940.920.990.850.930.890.75-0.140.660.720.980.750.840.740.870.850.980.840.890.87-0.580.650.920.950.88
0.640.620.580.610.750.680.85-0.580.140.470.780.860.790.70.70.760.60.720.440.5-0.550.650.670.640.55
1.00.850.940.990.980.990.86-0.120.740.920.920.860.80.610.760.860.940.750.930.89-0.690.920.670.870.98
0.880.990.930.80.850.820.78-0.290.610.660.930.770.930.860.950.850.930.940.840.8-0.580.950.640.870.82
0.990.80.910.990.930.960.810.020.830.960.850.810.710.490.680.780.920.660.960.91-0.660.880.550.980.82
Click cells to compare fundamentals

Cansino Biologics Account Relationship Matchups

Cansino Biologics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.8B6.7B11.9B11.5B9.3B6.7B
Other Current Liab57.7M142.3M544.4M637.0M732.5M769.2M
Total Current Liabilities116.4M409.5M2.9B2.9B2.6B1.4B
Total Stockholder Equity1.5B6.1B8.0B6.7B5.3B4.5B
Other Liab59.8M174.0M202.0M222.4M255.7M134.3M
Net Tangible Assets1.5B6.0B7.8B6.5B7.5B4.2B
Retained Earnings(368.1M)(764.7M)1.1B42.7M(1.6B)(1.5B)
Accounts Payable6.2M60.6M842.6M253.1M104.0M200.3M
Cash202.5M4.4B5.5B3.4B2.0B2.5B
Non Current Assets Total990.3M1.3B2.6B3.7B4.1B2.2B
Other Assets88.7M151.1M148.6M398.7M458.5M481.5M
Long Term Debt130M90M40M878.0M1.1B1.1B
Net Receivables15.4K21.6M157.9M855.5M636.9M668.7M
Short Term Investments552.3M666.6M2.3B2.6B2.1B1.4B
Non Current Liabilities Total189.7M264.4M451.4M1.3B1.4B1.5B
Inventory16.3M170.5M875.6M677.8M350.7M330.2M
Other Current Assets23.1M114.1M454.5M245.0M281.8M181.3M
Total Liab314.0M677.2M3.3B4.2B4.0B2.1B
Deferred Long Term Liab52.2M43.4M26.2M52.0M59.7M41.5M
Net Invested Capital1.6B6.2B9.1B9.2B7.7B5.5B
Short Long Term Debt20.2M40.2M1.1B1.6B1.4B1.5B
Total Current Assets794.2M5.4B9.3B7.7B5.2B4.6B
Net Working Capital670.0M5.0B6.4B4.8B2.6B3.1B
Intangible Assets57.2M72.3M198.3M258.7M205.6M138.9M
Property Plant Equipment574.9M873.9M2.2B3.1B3.5B3.7B

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

Balance Sheet is a snapshot of the financial position of Cansino Biologics at a specified time, usually calculated after every quarter, six months, or one year. Cansino Biologics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cansino Biologics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cansino currently owns. An asset can also be divided into two categories, current and non-current.